a potential therapy for Covid-19 | Exclusive News

Jubilant Life Sciences Limited enters into Licensing Agreement with Gilead for Remdesivir, a potential therapy for Covid-19

By editor3 on May 12, 2020May 12, 2020

Continue reading

Live Updates COVID-19 CASES

World 114,552,911

World

Confirmed: 114,552,911

Active: 21,961,049

Recovered: 90,051,580

Death: 2,540,282
USA 29,207,485

USA

Confirmed: 29,207,485

Active: 9,050,116

Recovered: 19,632,572

Death: 524,797
India 11,112,012

India

Confirmed: 11,112,012

Active: 170,291

Recovered: 10,784,528

Death: 157,193
Brazil 10,517,232

Brazil

Confirmed: 10,517,232

Active: 876,529

Recovered: 9,386,440

Death: 254,263
France 3,736,016

France

Confirmed: 3,736,016

Active: 3,394,816

Recovered: 254,868

Death: 86,332
Italy 2,925,265

Italy

Confirmed: 2,925,265

Active: 422,367

Recovered: 2,405,199

Death: 97,699
Germany 2,446,063

Germany

Confirmed: 2,446,063

Active: 127,038

Recovered: 2,248,400

Death: 70,625
Pakistan 579,973

Pakistan

Confirmed: 579,973

Active: 21,836

Recovered: 545,277

Death: 12,860
Bangladesh 546,216

Bangladesh

Confirmed: 546,216

Active: 40,884

Recovered: 496,924

Death: 8,408
China 89,893

China

Confirmed: 89,893

Active: 218

Recovered: 85,039

Death: 4,636
Sri Lanka 83,094

Sri Lanka

Confirmed: 83,094

Active: 3,683

Recovered: 78,947

Death: 464
Afghanistan 55,733

Afghanistan

Confirmed: 55,733

Active: 3,956

Recovered: 49,333

Death: 2,444